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Dysfunction and loss of retinal pigment epithelium
(RPE) leads to degeneration of photoreceptors in
age-related macular degeneration and subtypes of
retinitis pigmentosa. Human embryonic stem cells
(hESCs) may serve as an unlimited source of RPE
cells for transplantation in these blinding conditions.
Here we show the directed differentiation of hESCs
toward an RPE fate under defined culture conditions.
We demonstrate that nicotinamide promotes the
differentiation of hESCs to neural and subsequently
to RPE fate. In the presence of nicotinamide, factors
from the TGF-b superfamily, which presumably
pattern RPE development during embryogenesis,
further direct RPE differentiation. The hESC-derived
pigmented cells exhibit the morphology, marker
expression, and function of authentic RPE and
rescue retinal structure and function after transplan-
tation to an animal model of retinal degeneration
caused by RPE dysfunction. These results are an
important step toward the future use of hESCs to
replenish RPE in blinding diseases.
INTRODUCTION
The retinal pigment epithelium (RPE), which is a monolayer of
cells between the neural retina and the choriocapillaris, plays
crucial roles in the maintenance and function of the retina and
its photoreceptors. These include the formation of the blood-
retinal barrier, absorption of stray light, supply of nutrients to
the neural retina, regeneration of visual pigment, and uptake
and recycling of shed outer segments of photoreceptors
(Strauss, 2005).
Dysfunction, degeneration, and loss of RPE cells are promi-
nent features of Best disease, subtypes of retinitis pigmentosa396 Cell Stem Cell 5, 396–408, October 2, 2009 ª2009 Elsevier Inc(RP), and age-related macular degeneration (AMD), which is
the leading cause of visual disability in the western world. In
these conditions, there is progressive visual loss that often leads
to blindness. A variety of therapeutic approaches to delay the
degenerative process are under development, but the grim
reality is that many patients eventually lose their sight. Cell
therapy to replenish the degenerating RPE cells may potentially
halt disease progression (da Cruz et al., 2007). In animal models
of retinal degeneration, photoreceptor rescue and preservation
of visual function have been demonstrated after subretinal trans-
plantation of RPE cells (Coffey et al., 2002; Lin et al., 1996; Little
et al., 1996; Sauve et al., 2002). Partial restoration of visual func-
tion was also reported in humans, mainly after autologous RPE
layer transplantation (da Cruz et al., 2007).
Human embryonic stem cells (hESC) may serve as an unlim-
ited donor source of RPE cells for transplantation (Haruta,
2005). The potential of mouse, primate, and human ESCs to
differentiate into RPE-like cells (Aoki et al., 2006; Haruta et al.,
2004; Klimanskaya et al., 2004), to attenuate retinal degenera-
tion, and to preserve visual function after subretinal transplanta-
tion has been demonstrated (Haruta et al., 2004; Lund et al.,
2006; Vugler et al., 2008). In the hESC system, putative RPE cells
could be harvested after spontaneous differentiation at a rela-
tively low efficiency (Klimanskaya et al., 2004). More recently,
improved yield of RPE-like cells was obtained after induced
differentiation of hESCs with Wnt and Nodal antagonists and
prolonged culture (Osakada et al., 2008).
Here, we developed defined culture conditions to direct the
differentiation of hESCs into cultures enriched for functional
RPE-like cells. We show that differentiation toward neural and
further toward RPE fate is augmented by nicotinamide (vitamin
B3; NIC). We further show, in line with evidence for the key
role of TGF-b superfamily factors in embryonic RPE patterning
(Fuhrmann et al., 2000), that Activin A, in the presence of NIC,
efficiently induces and augments differentiation into RPE cells
within 4 weeks. Transplantation of these RPE cells into an animal
model of retinal degeneration caused by RPE dysfunction
protects photoreceptors and rescues retinal function, and the.
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Directed Differentiation of hESCs to Functional RPEengrafted cells are capable of uptaking the visual pigment
rhodopsin, suggesting their phagocytic function in vivo.
RESULTS
Development of hESC-Derived Pigmented Cells
Given the role of NIC in cell metabolism, survival, plasticity, and
differentiation (Li et al., 2006; Otonkoski et al., 1993), we sought
to study its effect on the differentiation of hESCs. We analyzed
the gene expression profile of hESCs (HES1 line) after 4 weeks
of spontaneous differentiation as free-floating clusters in the
presence and absence of NIC by using genome-scale microar-
rays. Functional classification analysis of differentially expressed
genes via Onto-Tools (Draghici et al., 2003) showed that the
hematopoietic and the melanogenic differentiation pathways
were significantly enriched (p = 2.7 3 104 and p = 5.7 3 103,
respectively) in the presence of NIC (Table S1 available online).
The expression of neural, early retinal, and RPE genes was upre-
gulated above 4-fold in the presence of NIC (Table S2). In addi-
tion, NIC promoted the appearance of pigmented areas within
the differentiating hESC clusters. Given these results, we further
studied the effect of NIC on RPE differentiation.
In serum-free medium supplemented with NIC, pigmented
areas began to appear within the differentiating clusters after
Figure 1. NIC Induces Differentiation into
Pigmented Cells
(A) Dark-field micrographs showing the appear-
ance of pigmented cells after 8 week culture of
hESC-derived clusters in the presence or absence
of NIC.
(B) Phase contrast and fluorescence images of
pigmented cells immunoreactive with both anti-
Otx2 and -MiTF (arrows) after 6 weeks of differen-
tiation.
(C and D) Histogram presentation of the
percentage of clusters containing pigmented
areas (C) and of pigmented cells within the clusters
(D) at different time points during differentiation
with (blue) or without (green) NIC.
Scale bars represent 200 mm in (A) and 20 mm in
(B).*p < 0.05; **p % 2 3 104; bars represent
mean ± SEM.
4 weeks, and 72.9% ± 2.5% of the
hESC clusters had pigmented cells after
8 weeks of differentiation. In the absence
of NIC, pigmented areas were not ob-
served after 4 weeks, and only 13.1% ±
4.8% of the hESC clusters developed
pigmented areas after 8 weeks (Figures
1A and 1C). Within clusters that differenti-
ated 8 weeks in the presence of NIC,
5.7% ± 1.0% of the cells were pigmented
(Figure 1D), 5.4% ± 1.1% expressed the
early RPE marker MiTF, and in most
cases the expression of MiTF correlated
with pigmentation (Figure 1B). Most of
the MiTF-expressing pigmented cells
coexpressed Otx2, similar to naturally
developing RPE cells in the embryonic eye (Figure 1B). The effect
of NIC on differentiation toward pigmented cells was confirmed
in additional hESC lines (H7 and HES4; Figure S1).
Developmental Progression toward RPE Fate
in Differentiating hESC Clusters
To determine whether the development of RPE cells in vitro reca-
pitulates the key developmental steps of RPE in vivo, we per-
formed time-course analysis of the expression within the hESC
clusters of keymarkers during RPE development. Clusters differ-
entiating in the presence or absence of NIC were analyzed by
Q-PCR, FACS, and immunostaining for the expression of
markers of undifferentiated hESCs, early neural differentiation,
retinal, and RPE development (Figure 2). In the presence of
NIC, the expression of markers of undifferentiated hESCs
(Oct4, Figure 2A; TRA-1-60, Figure 2B) declined more rapidly
and the process of early neural differentiation was promoted.
NIC treatment increased the expression of transcripts of the
early neural markers Otx2, Musashi, and Pax6 after 2, 4–6, and
2–6 weeks of differentiation, respectively (Figure 2A). FACS anal-
ysis after 4 weeks of differentiation in the presence of NIC
showed that 81.3% ± 6.3% of the cells expressed the neural
precursor marker polysialic acid-neural cell adhesion molecule
(PSA-NCAM), as compared to 14.4% ± 5.9% in control clustersCell Stem Cell 5, 396–408, October 2, 2009 ª2009 Elsevier Inc. 397
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Directed Differentiation of hESCs to Functional RPEFigure 2. Time-Course Analysis of the Progression through Neural, Retinal, and RPE Differentiation in the Presence of NIC
(A) Q-PCR analysis, at sequential time points, of the expression of key genes in neural, retinal, and RPE development in hESC clusters cultured 8 weeks in the
presence (blue) or absence (green) of NIC.
(B) FACS analysis of the expression of TRA-1-60 and PSA-NCAM, in clusters differentiating 6 weeks with (blue) or without (green) NIC.
(C) Analysis of the percentage of cells immunoreactive with anti-PSA-NCAM, Nestin, and Musashi antibodies within clusters differentiating 2 and 4 weeks
with NIC.
(D) Immunofluorescence images, demonstrating the expression of the above markers in NIC-treated cells, 2 hr after cluster dissociation and cell plating.
Scale bars represent 20 mm; *p < 0.05, **p% 0.005; bars represent mean ± SEM. Relative quantity = relative expression level of each gene in comparison to its
expression level on day 0 that was set at 1.(Figure 2B). Immunostaining confirmed that at 4 weeks, the
majority of cells within the NIC-treated clusters acquired a
neural phenotype and expressed PSA-NCAM (76.4% ± 3.8%),
Nestin (63.4% ± 10.3%), and Musashi (81.1% ± 4.9%; Figures
2C and 2D).
The gene expression microarray analysis of differentiating
hESCs showed that NIC treatment decreased the expression
level of genes associated with apoptosis by R2.94-fold
(Figure S2A). A potential antiapoptotic effect of NIC was further
suggested by FACS analysis of the percentage of Annexin V+
apoptotic cells, whichwas significantly reduced in hESC clusters
after 2 weeks’ differentiation in the presence of NIC compared to
its absence (Figure S2B). Moreover, within the NIC-treated cell
population, the percentage of Annexin V+ cells was significantly398 Cell Stem Cell 5, 396–408, October 2, 2009 ª2009 Elsevier Inc.lower among PSA-NCAM+ neural cells compared to PSA-
NCAM nonneural cells (Figure S2C).
With regard to proliferation, immunostaining showed similar
percentages of Ki67+ cells as well as similar percentages of
proliferating neural cells coexpressing Nestin and Ki67 in the
presence and absence of NIC (Figures S2D and S2E).
Collectively, these results suggest that prevention of
apoptosis of neural cells, rather than augmentation of their prolif-
eration, was one mechanism underlying the promotion of neural
differentiation by NIC.
After 2 weeks of initial differentiation, NIC induced the expres-
sion of transcripts of Bf1, an anterior neural marker, whereas
NIC had no effect on the level of expression of markers of
midbrain (En1) and caudal (HoxC5) specification (Figure S3A).
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emerging early multipotent neural precursors have an anterior
phenotype (Pankratz et al., 2007). It appears that NIC augmented
this early step of differentiation into neural precursors with an
anterior phenotype.
The expression of transcripts of Rx1 and Six3 transcription
factors, which have a key role in retinal specification, was
demonstrated after 2 weeks of differentiation. In the presence
of NIC, the expression of these genes as well as Chx10, which
regulates the proliferation of neural retinal progenitors, was
increased (Figure 2A). The expression of Rx1 relative to the
forebrain markers Bf1 or Otx2 was higher in the presence of
NIC compared to its absence (Figures S3B and S3C), suggesting
that NIC augmented retinal specification in addition to promoting
anterior neuralization.
In the presence of NIC, the expression of transcripts of the
early RPE marker MiTF-A, RPE65, and of the more mature
RPE marker Bestrophin was also augmented mainly after 4
and 8 weeks, respectively (Figure 2A).
To determine the time at which NIC excreted its RPE inductive
effect, we supplemented NIC at different time periods and
analyzed its effect on the percentage of pigmented clusters
(Figure S3D). NIC augmented RPE differentiation when applied
during the first 4 weeks of culture, when neural and retinal spec-
ification occur. NIC did not augment RPEdifferentiation if supple-
mented during weeks 4 to 6, at the time window when eye field
specification has occurred (see Figure 2A, green bars at 4 weeks
for Six3 and Rx) and further retinal differentiation took place (see
Figure 2A, green bars at 4 and 6 weeks for RPE65 and Chx10).
In summary, the differentiation process of RPE within hESC
clusters in vitro followed the steps that occur during embryonic
development of RPE in vivo. NIC augmented this process mainly
at the stage of early neural specification.
Factors from the TGF-b Family Enhance the Appearance
of Pigmented Cells
The process of RPE differentiation in our system mimicked RPE
development in the embryo, so we sought to evaluate whether
factors that play a key role in specification and patterning of
the RPE during eye development would also augment the differ-
entiation of hESCs into RPE. Studies in the chick suggest that ex-
traocular mesencymal-derived Activin or other factors from the
TGF-b superfamily have a key role in patterning the optic vesicle
into RPE (Fuhrmann et al., 2000). To test the possible role of ac-
tivin signaling in our hESC differentiation system, we first demon-
strated the expression of activin receptors and Activin A, after
2 weeks’ differentiation in the presence of NIC (Figure 3G). At
this time, the expression of early eye field markers was emerging
(Figure 2A) and therefore the differentiating hESCs were prob-
ably at a developmental stage paralleling the early optic vesicle.
Although transcripts of the receptors ACTRIB and ACTRIIB were
expressed in the presence of NIC, no or minor expression was
observed in its absence. These observations were supported
by the Affymetrix gene expression analysis that showed, in the
presence of NIC, a significant (p = 0.026) enrichment of the
TGF-b signaling pathway among differentially expressed genes
(Table S1).
In the presence of NIC, Activin A significantly augmented the
appearance of pigmented areas within hESC clusters differenti-ating for 4 weeks (Figures 3A and 3B). In the absence of NIC, the
effect of Activin A treatment was not prominent (Figure 3C) and
therefore further studies of the effects of Activin A were per-
formed in the presence of NIC. Supplementation of Activin A
for 2 weeks after initial 2 weeks’ differentiation was optimal for
enhancing RPE differentiation (data not shown). Activin A
treatment significantly increased the percentage of clusters
that included pigmented cells (50.7 ± 6.5 versus 17.7 ± 3.2;
Figure 3H) and the percentage of pigmented cells from the total
number of cells (9.9 ± 1.4 versus 2.4 ± 1.2; Figure 3I). This obser-
vation was confirmed in additional hESC lines (H7, HES4;
Figure S1). The effect of Activin A on RPE differentiation
was dose dependent, with optimal effect at a concentration of
140 ng/ml (Figure S4).
The effect of Activin A on differentiation into pigmented
clusters was significantly attenuated in the presence of
SB431542, which is a selective inhibitor of TGF-b superfamily
type I receptors (Figures 3E and 3H; Inman et al., 2002). Further-
more, in the absence of Activin A, the percentage of pigmented
clusters was reduced after differentiation in the presence of
NIC+SB431542 compared to NIC alone (Figure 3H). This effect
was probably related to blocking of endogenous Activin A
signaling (Figure 3G).
Q-PCR time-course analysis showed that Activin A treatment
augmented the expression of MiTF isoforms and Bestrophin,
a marker of more mature RPE cells, after 2.5–4 weeks and
6–8 weeks of differentiation, respectively (Figure 3J).
An inductive effect on RPE differentiation, similar to that of
Activin A, was also observed with TGF-b1, another member of
the TGF-b superfamily (Figures 3D and 3H). In contrast, treat-
ment with basic FGF (bFGF) in the presence of NIC abolished
the appearance of pigmented cells (Figure 3F).
The accessibility of cells within clusters to differentiation-
inducing factors in the culture medium may be limited, so we
modified the differentiation conditions to include a stage of
monolayer culture growth. Differentiation in the presence of
NIC was initiated for a week within free-floating clusters, which
were plated to form monolayer cultures of cells during the
second week. Activin A was supplemented to the monolayer
cultures during the third and fourth weeks. With this modifica-
tion, the yield of RPE-like pigmented cells at 6 weeks was
25.2% ± 2.4% with NIC without Activin A treatment and further
significantly improved to 33.4% ± 3.8% with Activin A supple-
mentation (p < 0.05). This yield was significantly improved
compared to the percentage of pigmented cells (10.1% ± 3.0%)
obtained within clusters differentiating in suspension.
Human ESC-Derived Pigmented Cells Are Putative
RPE Cells
To characterize the phenotype of the pigmented cells, hESC-
differentiated clusters containing pigmented areas were partially
dissociated and plated. Colonies comprised of a monolayer of
the pigmented cells emerged between other types of differenti-
ated cells (Figure 4A). The pigmented cells within the colonies
acquired a polygonal shape and formed ‘‘cobble stone’’-like
sheets of cells (Figures 4B and 4C). Immunostaining with anti-
ZO-1 showed that the cells were connected by tight junctions
(Figure 4G). Electron microscopy analysis demonstrated that
the hESC-derived pigmented cells hadmorphological propertiesCell Stem Cell 5, 396–408, October 2, 2009 ª2009 Elsevier Inc. 399
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Directed Differentiation of hESCs to Functional RPEFigure 3. Factors from the TGF-b Superfamily Promote Differentiation toward RPE Fate
(A–F) Dark-field micrographs of hESC-derived clusters, after 4 weeks of differentiation, showing an increase in the development of pigmented clusters in the
presence of Activin A and NIC (B) as opposed to NIC only (A) or to Activin A only (C). Supplementation with TGF-b1 also increases the appearance of pigmented
clusters (D), whereas the inhibitor of activin signaling SB431542 reduces the effect of Activin A (E). bFGF abolishes the development of pigmented clusters (F).
(G) RT-PCR analysis of the expression of activin receptors and Activin A in clusters differentiating 2 weeks with and without NIC and in undifferentiated hESCs.
(H) Histogram presentation of the percentage of clusters containing pigmented areas after 4 weeks culture in the presence of NIC, NIC+SB (5, 50 mM), NIC+Act,
NIC+Act+SB (5, 50 mM), NIC+TGF-b1.
(I) Histogram presentation of the percentage of pigmented cells after 4 weeks of culture with NIC (blue) or with NIC and Act (pink).
(J) Time-course Q-PCR analysis of the effect of Activin A on the expression levels of RPEmarker genes in hESCs differentiating in the presence of NIC (blue) or NIC
and Activin A (pink).
Scale bars represent 200 mm; Act, Activin A; SB, SB431542; *p < 0.05; **p% 0.005; bars represent mean ± SEM. Relative quantity = relative expression level of
each gene in comparison to its expression level in cells treated with NIC only at 2.5 weeks that was set at 1 (J).that are highly characteristic of native RPE cells in vivo (Figures
4M–4O).
Phalloidin staining showed F-actin distribution adjacent to the
cell membrane, similar to naturally developing RPE cells
(Figure 4D). Immunostaining showed that the pigmented cells
expressed markers of both early and mature RPE cells (Figures400 Cell Stem Cell 5, 396–408, October 2, 2009 ª2009 Elsevier Inc.4E, 4F, and 4H–4J). Q-PCR analysis of differentiating hESC-
clusters showed minimal, NIC-independent expression of
Sox10, which is a marker of neural crest-derived melanocytes,
compared to control cells of the M51 melanoma cell line
(Figure 2A), further indicating that the majority of pigmented cells
were not melanocytes but rather RPE-like cells.
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Are Putative RPE Cells
(A) Dark-field micrograph illustrating differentiated
clusters after plating with confined pigmented
areas.
(B and C) Phase-contrast images at low (B) and
high (C) magnification of pigmented cells.
(D) Phalloidine staining showing distribution of
F-actin adjacent to the cell membrane.
(E–J) Immunostaining showing that the pigmented
cells express markers of early (MiTF (E), Pax6 (F))
and mature (ZO-1 (G), RPE65 (H), CRALBP (I),
Bestrophin (J)) RPE.
(K) After dissociation, plating at low density, and
cultivation, the pigmented cells lose pigmentation
and acquire fibroblast-like morphology (phase-
contrast image, 1 week of culture).
(L) After 6 weeks’ proliferation into high-density
cultures, the cells reacquire the morphology and
pigmentation of RPE cells.
(M–O) Electron microscopic analysis of hESC-
derived RPE cells showing features charac-
teristic of RPE: apical microvilli and melanin
granules (M), a basal membrane (N), and tight
junctions (O).
(P and Q) Differential interference contrast (DIC;
(P)) and a z-stack fluorescent image with cross-
section side views: x-z and y-z (Q), showing
phagocytosis of a green fluorescent latex bead
(arrowheads) by the hESC-derived pigmented
cells; the membranes are stained with red fluo-
rescent dye PKH.
(R) Z-stack fluorescent image combined with DIC
with cross-section side views: x-z and y-z
showing phagocytosis of mouse purified fluores-
cent (blue) outer segments by pigmented cells.
Nuclei were counterstained with DRAQ5 (red)
and may be masked by the black pigment (arrow-
head marks a representative pigmented cell).
Nuclei were counterstained with DAPI in (D)–(F),
(H), (I), (Q). Scale bars represent 200 mm in (A),
40 mm in (B), 20 mm in (C)–(L), 1000 nm in (M),
500 nm in (N), 100 nm in (O), 10 mm in (P)–(S).It was possible to further enrich the cultures for RPE-like cells
andexpand them.Pigmentedareasweremechanically dissected
from differentiating clusters, dissociated, and plated. The cells
acquiredafibroblast-likeappearanceand lost their pigmentation,
suggesting regression from their differentiated RPE-like state
(Figure 4K). However, after an additional 4–6 weeks, cell density
increased and the cells again acquired pigmentation and
assumed a polygonal shape (Figure 4L). These data together
with previous work (Klimanskaya et al., 2004) suggest that prop-
agation and expansion of RPE cells may be possible.
One of the most important functions of RPE cells in vivo is
phagocytosis of shed photoreceptor outer segments, as part
of the continuous renewal process of rods and cones. Confocal
microscopy analysis of hESC-derived pigmented cells afterincubation with fluorescent latex beads or mouse purified fluo-
rescent photoreceptor outer segments showed that they could
phagocyte both (Figures 4P–4R and Movies S1 and S2).
Survival and Incorporation of hESC-Derived RPE Cells
after Transplantation into Dystrophic RCS Rat Eyes
The potential therapeutic effect of the hESC-derived pigmented
cells was studied after subretinal transplantation in the Royal
College of Surgeon (RCS) rat animal model in which primary
dysfunction of the RPE occurs as a result of a mutation in the
receptor tyrosine kinase gene Mertk (D’Cruz et al., 2000). This
leads to impaired phagocytosis of shed photoreceptor outer
segments, with secondary degeneration and loss of photorecep-
tors within the first months of life.Cell Stem Cell 5, 396–408, October 2, 2009 ª2009 Elsevier Inc. 401
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constitutively expressing eGFP (Gropp et al., 2003). Pigmented
areas within differentiating eGFP+ hESC clusters were mechan-
ically isolated and disaggregated, and 0.6–13 105 cells (of which
49%–69% were pigmented) were engrafted into the subretinal
space of 29 3-week-old RCS rats. Intravitreal transplanted
eyes, fellow nontransplanted eyes, vehicle-transplanted eyes,
and human fibroblast-transplanted eyes served as four types
of controls.
Retinal function and structure was studied 5–6 weeks post-
transplantation in 21 rats (Figures 5 and 6). In order to assess
long-term effects of transplantation and to substantiate efficacy
and safety, eight rats were followed up to 19 weeks posttrans-
plantation (Figure S5).
5–6 weeks after transplantation, the transplanted pigmented
cells could be readily identified by standard color andSLO-based
Figure 5. hESC-Derived RPE Cells Survive,
Integrate, and Express RPE Markers after
Subretinal Transplantation in RCS Rat Eyes
(A–C) Fundus imaging of subretinal grafts of
pigmented cells in eyes of live RCS rats; fundus
photo (A) and red-free photo (B) (note retinal
vessels crossing over the pigmented areas). (C)
The grafted eGFP+ cells emit fluorescence, as
evident by the hyperfluorescent areas (arrowhead)
surrounding the pigmented grafts.
(D and E) Fluorescence microscope images of eye
cup preparations, showing large clusters (D) as
well as multiple dispersed smaller clusters (E) of
subretinal eGFP+ cells.
(F–I) Immunostaining with anti-GFP showing the
subretinal location of grafts dispersed in large
areas (F, H) and pigmented cells coexpressing
eGFP (G, I). Note eGFP+ cells integrating within
the host RPE layer (G); arrows showing host RPE.
(J–O) Immunostaining showing eGFP+ trans-
planted cells coexpressing RPE65 (J, K), Bestro-
phin (L, M), and ZO-1 (N, O).
(J, L, N) Left-most panel in each row shows
low-magnification fluorescent image of grafts
coexpressing eGFP and the relevant marker.
(K, M, O) High-magnification confocal images
in each row show from left to right pigment (by
Nomarski optics) and coexpression of the different
RPEmarkers and eGFP. Note the polygonal shape
of eGFP+ cells in (M) and (O).
fundus imaging systems (Figures 5A and
5B), and their eGFP fluorescence emis-
sion was detected when fluorescein exci-
tation and emission filters were used
(Figure 5C). Large clusters of subretinal
eGFP+ cells (Figure 5D) as well as
multiple, dispersed smaller clusters
(Figure 5E) could be observed by a fluo-
rescence microscope in enucleated eye
cups.
Histologic and immunostaining anal-
ysis 5–6 weeks after transplantation
showed the subretinal location of eGFP+
pigmented cells (Figures 5F–5I). Grafts
were often dispersed over a large area (Figures 5F and 5H),
and pigmented cells coexpressing eGFP were clearly identified
(Figures 5G and 5I). Occasionally, eGFP+ cells integrated within
the host RPE (Figure 5G). Within well-defined grafts, 36.2% ±
7.2% of transplanted cells were pigmented (n = 6 eyes). Multiple
transplanted cells expressed markers specific for mature RPE
including RPE65 (Figures 5J and 5K) and Bestrophin (Figures
5L and 5M). The transplanted cells also formed tight junctions
(Figures 5N and 5O), which is important for maintaining the
blood-retinal barrier. Transplanted cells with polygonal shape
were observed (Figures 5M and 5O).
Further studies at 19weeks posttransplantation demonstrated
that the engrafted eGFP+ cells survived in the subretinal space
and maintained the expression of RPE65 (Figures S5D–S5F).
The majority of eGFP+ transplanted cells (89.4% ± 2.3%; n = 3)
expressed RPE65.402 Cell Stem Cell 5, 396–408, October 2, 2009 ª2009 Elsevier Inc.
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Directed Differentiation of hESCs to Functional RPEFigure 6. Transplanted hESC-Derived RPE Cells Provide Functional and Structural Rescue in the RCS Rat Model of Retinal Degeneration
(A) Representative full-field ERG responses to a series of white flashes of increasing intensity in the DA state in a transplanted eye and its fellow nontransplanted
eye.
(B) Mean b-wave amplitudes in response to white flashes of increasing intensity. Note significantly (p < 0.05) higher amplitudes in transplanted eyes (black line) as
compared to groups of control eyes at all intensities equal to or above 0.048 cd$s/m2.
(C) Images of H&E-stained sections, showing relative preservation of ONL and thicker IS+OS layer in proximity to a subretinal RPE graft (located between arrow-
heads) as compared with thin ONL and segments distant from the graft. Inserts in (C) are higher-magnification images of the retina in proximity (black insert) and
distant (red insert) from the grafts.
(D) Total retinal, ONL, and IS+OS thicknesses are significantly increased in vicinity to grafts (black bars), as compared to areas distant from grafts (red bars; n = 8;
p < 5 3 105).
(E) Confocal immunofluorescence images of subretinal transplanted RPE cells showing the colocalization of pigment, eGFP, RPE65, and Rhodopsin within the
same single cells. The native RPE cells of the RCS rat (arrow) express RPE65 but do not express eGFP and contain minimal amounts of Rhodopsin. Bars repre-
sent mean ± SEM.Importantly, tumor masses or teratomas were not observed in
the 29 transplanted eyes by in vivo imaging and histology up to
19 weeks posttransplantation.
Transplanted hESC-Derived RPE Cells Provide
Functional and Structural Retinal Rescue
In RCS rats, retinal function is severely impaired by 2–3 months
of age, with a corresponding loss of photoreceptors and thinning
of their nuclei layer (outer nuclear layer [ONL]) to less than one to
two rows. In transplanted eyes, 5–6 weeks postengraftment,
electroretinographic (ERG) recordings revealed a significant
preservation of retinal function as compared to control untreated
or medium-injected eyes (Figures 6A and 6B). The mean ampli-tudes of ERG responses to a series of white flashes of increasing
intensity in the dark-adapted (DA) state were significantly higher
in transplanted eyes (Figure 6B).
Long-term follow-up electroretinography studies showed
a significant functional rescue in transplanted eyes compared
to control fellow eyes up to 13 weeks postengraftment though
the ERG responses were attenuated at this stage (Figures
S5A and S5B). By 19 weeks postengraftment, full-field ERG
responses became unrecordable.
Histological analysis 5–6 weeks postengraftment showed
preservation of theONL and of the photoreceptor inner and outer
segments (IS+OS) in proximity to subretinal grafts as compared
with areas distant from the grafts (Figure 6C). In quantitativeCell Stem Cell 5, 396–408, October 2, 2009 ª2009 Elsevier Inc. 403
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significantly increased (by 53%, 109%, and 60%, respectively;
n = 8; p < 53 105) in vicinity to the grafts as compared to areas
distant from grafts (Figure 6D). Histological studies 19 weeks
posttransplantation, at the time when ERG responses became
unrecordable, still showed preservation of ONL in proximity to
the grafts compared to areas without subretinal eGFP+ cells
(ONL of two to three rows of nuclei compared to one row or
less; Figures S5C and S5D).
To confirm that the retinal rescue was not a nonspecific effect
that could be obtained after transplantation of any type of cells,
in a subset of RCS eyes (n = 14), human fibroblasts were trans-
planted into the subretinal space (Figure S6). When mitotically
active human Tenon’s capsule fibroblasts were transplanted,
disorganization of the host tissue was most commonly observed
accompanied by a marked inflammatory response (Figure S6A).
Transplanted mitomycin-treated human foreskin fibroblasts did
not proliferate and remained within the outer retina; however,
they did not confer protection of the photoreceptor layer
(Figure S6B).
Implantation of mammalian cells engineered to secrete CNTF
into the vitreous was previously shown to provide a neurotrophic
rescue effect in animal models of retinal degeneration (Tao et al.,
2002). To determine whether hESC-derived pigmented cells
have a similar trophic effect, they were engrafted into the vitreal
rather than the subretinal space. In all nine transplanted RCS rat
eyes, pigmented grafts were present in the vitreous, but rescue
of the ONL was not observed (Figure S7).
Failure to phagocytose shed photoreceptor outer segments is
the main functional impairment of the Mertk-mutated RPE in
RCS rats. In an attempt to determine whether the transplanted
hESC-derived pigmented cells can perform phagocytosis
in vivo, we examined whether they were uptaking Rhodopsin,
a major component of photoreceptor outer segments. Indeed,
confocal images showed colocalization of pigment, eGFP,
RPE65, and Rhodopsin within the same single subretinal trans-
planted RPE cells both at 6 (Figure 6E) and 19 weeks posten-
graftment (Figure S5F). Importantly, as expected, the native
eGFP, RPE65+ RPE cells of the RCS rats that have impaired
phagocytic ability contained just minimal amounts of Rhodopsin,
if at all (Figure 6E, arrows).
DISCUSSION
The present study demonstrates that NIC and Activin A can
promote, under defined culture conditions, the differentiation
of hESCs toward an RPE fate. The hESC-derived pigmented
cells exhibit the morphology, function, and marker expression
of authentic RPE and rescue retinal structure and function after
transplantation to an animal model of retinal degeneration.
In our system NIC promoted neural and subsequently RPE
differentiation. The promotion of neural differentiation was medi-
ated, at least in part, by prevention of apoptosis of neural cells.
NIC is a precursor of the coenzyme b-nicotinamide adenine
dinucleotide (NAD+), which functions in the production of ATP
in the mitochondria. In line with our findings, NIC was demon-
strated to increase cell survival (Chong et al., 2005) and has
a potent neuroprotective action in vitro (Shen et al., 2004). NIC
is an inhibitor of the enzyme Poly-ADP-Ribose Polymerase404 Cell Stem Cell 5, 396–408, October 2, 2009 ª2009 Elsevier Inc.(PARP), which is involved in DNA repair and cell death, including
retinal cell death (Paquet-Durand et al., 2007). Therefore, it may
be speculated that in our system NIC promoted neural and
retinal cell survival potentially by PARP inhibition. This is sup-
ported by a recent study demonstrating that PARP inhibition
by NIC rescues hESC-derived neural progenitors from cell death
and thus enhances neuralization (Cimadamore et al., 2009). NIC
is also a strong inhibitor of NAD-dependent histone deacetylase
(Imai et al., 2000), which is implicated in mediating gene silenc-
ing, longevity, and genome stability. Furthermore, members of
this enzyme family were recently shown to have a role in neural
cell fate determination in various redox states (Prozorovski
et al., 2008). Additional studies are required to further elucidate
the precise mechanism underlying the effect of NIC on differen-
tiation into RPE cells.
In the presence of NIC, the process of hESC differentiation
toward RPE was augmented and recapitulated the key steps
of RPE development in vivo. In the embryo, the eyes originate
from the forebrain as bilateral evaginations (optic vesicles)
comprised of progenitors expressing eye field markers, which
can give rise to both neural retina and RPE. Similar to embryonic
eye development, in our system, NIC initially significantly
promoted differentiation into neural precursors with a forebrain
phenotype, which was followed by differentiation into progeni-
tors expressing eye field markers and then further RPE differen-
tiation. We showed that prevention of apoptosis was one mech-
anism mediating the promotion of neural specification by NIC.
Clonal analysis would be required to determine whether NIC
had a neural inductive effect on pluripotent stem cells or only
an antiapoptotic effect on spontaneously emerging neuroecto-
dermal precursors.
The effect of NIC on RPE differentiation was further
augmented by Activin A. This is in line with the presumed role
of Activin A in RPE development in vivo. In the embryo, extraoc-
ular mesenchyme-secreted members of the TGF-b superfamily
are thought to direct the differentiation of the optic vesicle into
RPE (Fuhrmann et al., 2000). In our system, the optimal time
window for Activin A supplementation was at the period at
which the expression of markers of optic vesicle was upregu-
lated, suggesting that Activin A exerted its effect on progenitors
at a similar differentiation stage as the progenitors within the
optic vesicles.
Induction of activin signaling is specifically mediated through
its binding to both activin receptor IB together with receptors
IIA or IIB (Harrison et al., 2003), whereas receptor IA mediates
BMP signaling. At 2–4 weeks of hESC differentiation, coexpres-
sion of the activin receptors IB and II was observed in the pres-
ence of NIC, whereas activin receptor IB was not expressed
without NIC. Concordantly, Activin A significantly augmented
the appearance of pigmented cells after NIC pretreatment,
when the cells expressed the appropriate receptors and could
respond, whereas Activin A had no inductive effect in the
absence of NIC. Substituting Activin A with bFGF abolished
the differentiation of hESCs toward pigmented cells. This is in
line with the suggested role of FGFs in directing the differentia-
tion of the embryonic optic vesicle toward neural retina rather
than RPE (Martinez-Morales et al., 2004).
The reported yield of RPE cells after 4–8 weeks of sponta-
neous differentiation is relatively low, and less than 1% of EBs
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recently improved by induction of differentiation with Wnt and
Nodal antagonists, giving rise to pigmented cells within 38% of
the hESC colonies after 8 weeks (Osakada et al., 2008). In our
suspension system, within 4 weeks of differentiation, 51% of
the clusters contained pigmented areas whereas more than
70% were pigmented after 8 weeks. With the monolayer modifi-
cation, 33% of the cells were pigmented after 6 weeks.
After subretinal transplantation into RCS rats, the engrafted
cells integrated, salvaged photoreceptors in proximity to the
grafts, and rescued retinal function as also shown by others
(Lund et al., 2006; Vugler et al., 2008). These results are in line
with the photoreceptor rescue reported after transplantation of
primary RPE cells (da Cruz et al., 2007; Little et al., 1996). 89%
of the transplanted cells expressed RPE65, suggesting that the
majority of cells within the grafts were RPE-like cells. Less then
half of the cells within the grafts were pigmented, suggesting
the presence of immature RPE-like cells within the transplanted
cell population and the grafts. Improved purification of the pig-
mented cells prior to transplantation may improve the homoge-
neity of pigmented cells within the grafts. Although teratomas
or tumor masses were not observed during 19 weeks’ follow-
up, additional long-term safety studies are required to confirm
the safety of transplantation of hESC-derived RPE cells.
Fusion of the engrafted cells with host RPE cells could poten-
tially contribute to the RPE-like phenotype of eGFP+ cells.
Although our data can not exclude this possibility, the fact that
the majority of cells within the transplanted population were
pigmented RPE-like cells and the abundant RPE65+ and pig-
mented cells in intravitreal grafts, where fusion could not occur,
suggest that fusion events did not have a major contribution to
the presence of pigmented cells within the grafts.
In this study, a cell suspension was injected to the subretinal
space giving rise to multilayer grafts. This approach was
required for subretinal cell delivery in the relatively small eyes
of RCS rats. Alternative and potentially preferable approaches
such as engraftment of monolayer cell sheets (Kubota et al.,
2006) may be used in large animals and in future clinical
transplantations.
In the present study, compelling evidences support the RPE-
like nature of transplanted cells and their retinal rescue effect.
This protection could be related to a nonspecific effect of the
surgical procedure, trophic effect of the transplanted cells, or
their actual function as RPE cells. Transplanted medium or
human fibroblasts did not provide retinal protection, so it
appears that the surgical procedure in itself did not contribute
to the rescue and that at least some cell-specific features are
required for the beneficial effect. With regard to a potential
trophic effect, vitreous-transplanted hESC-derived pigmented
cells did not rescue the retinas from degeneration via a potential
trophic mechanism, although a trophic effect could still play
a role when the grafts were subretinal, in proximity to the photo-
receptors. The presence of Rhodopsin within subretinal trans-
planted pigmented cells, as also shown by Coffey (Vugler
et al., 2008), suggests that perhaps some RPE-like function
(phagocytosis of outer segments) was occurring in the areas of
structural rescue.
In conclusion, we show the directed differentiation of hESCs
toward functional RPE cells under defined culture conditions.CWhen transplanted into an animal model of retinal degeneration
caused by RPE dysfunction, they protected photoreceptors,
rescued retinal function, and could uptake Rhodopsin. These
results pave the way toward the future use of hESCs for cell
replacement of RPE in blinding diseases.
EXPERIMENTAL PROCEDURES
Cell Culture
Human ESCs (HES1 [Reubinoff et al., 2000] passages 24 to 41; HES4 [Taylor
et al., 2006] passage 55 to 63; H7 [Thomson et al., 1998] passage 42 to 46) and
eGFP+-HES1 cells (91% of total hESCs) (Gropp et al., 2003) with a normal
karyotype were cultured as described (Ben-Dor et al., 2006). For differentia-
tion, hESC colonies were picked up by means of collagenase IV (1 mg/ml;
GIBCO-BRL, Gaithersburg, MD), cultured as floating clusters in knockout
medium (KOM) comprised of KO-DMEM, 14% KO serum replacement, 1%
nonessential amino acids, 2 mM glutamine, 50 U/ml penicillin, 50 mg/ml
streptomycin (all from GIBCO-BRL), and 10 mM NIC (Sigma, St. Louis, MO)
in 6-well culture dishes (Costar, Corning Inc., Corning, NY) pretreated with
0.1% low-melting-temperature agarose (FMC BioProducts, Rockland, ME).
Alternatively, after the first week, the clusters were plated on laminin-coated
culture dishes (4 mg/cm2) for 5 weeks’ monolayer differentiation. Activin A
20–180 ng/ml (PeproTech Inc, Rocky Hill, NJ), TGF-b1 (2.5 ng/ml; R&D
Systems Inc., Minneapolis, MN), SB431542 (5 mM or 50 mM, Sigma),
and bFGF (20 ng/ml, PeproTech) were supplemented during the third and
fourth weeks.
For characterization, after 6–10 weeks in suspension, pigmented clusters
were triturated, plated on poly-D-lysine (30–70 kDa, 10 mg/ml) and laminin
(4 mg/ml, both from Sigma), and cultured in KOM+NIC for 3–5 weeks.
For expansion as a monolayer, after 8 weeks in suspension, pigmented
areaswere isolated by a surgical blade no. 15 and triturated and 30–50 clusters
were plated/dish (Falcon, Becton Dickinson and Company, Franklin Lakes,
NJ, cat. No 353037) precoated with poly-D-lysine and laminin and cul-
tured 6 weeks in KOM+NIC. The medium was replaced twice weekly. For
Affymetrix array analysis, hESC floating clusters were cultured 4 weeks in
DMEM (GIBCO-BRL) supplemented with fetal calf serum (10%, Hyclone,
Logan, UT).
Immunophenotyping
Clusters were dissociated with Papain Dissociation System (Worthington
Biochemical, Lakewood, NJ), plated on poly-D-lysine, incubated 2 hr in
KOM+NIC, fixed with 4% paraformaldehyde, and incubated with primary
and secondary antibodies (Supplemental Data) or Phalloidin (1:200, Sigma).
Nuclei were counterstained with 4, 6-diamidino-2-phenylindole (DAPI; Vector
Laboratories, Burlingame, CA). For quantification, 100–800 cells were scored
within random fields per marker or pigmentation inR3 experiments.
PCR Analysis
Total RNA was extracted from undifferentiated, differentiating hESCs andM51
human melanoma cell line (gift of Dr. M. Lotem) by means of TRI-Reagent
(Sigma). cDNA was synthesized with Moloney murine leukemia virus reverse
transcriptase (M-MLV RT) and random primers, according to the manufac-
turer’s instructions (Promega Corporation, Madison, WI). PCR was carried
out with Taq DNA Polymerase (GIBCO-BRL) with denaturation 94C; 15 s,
annealing 55C; 30 s, extension 72C; 45 s for 18–40 cycles. See primer
sequences in Supplemental Data.
For Q-PCR, TaqMan Assays-on-Demand Gene Expression Products
(Supplemental Data), TaqMan Universal PCR Master Mix, and ABI Prism
7900HT Sequence Detection System (Applied Biosystems, Foster City, CA)
were used. b-glucuronidase (GusB)was an internal reference for normalization.
Gene Expression Microarray Analysis
Gene expression microarray analysis was performed with Affymetrix Human
Genome U133A 2.0 Array (Santa Clara, CA), Affymetrix MAS 5.0 for data
normalization, Matlab 7.5.0 (R2007b) for group quantile normalization, and
SpotfireDecisionSite software for functional genomics.ell Stem Cell 5, 396–408, October 2, 2009 ª2009 Elsevier Inc. 405
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We performed fixation with 2% glutaraldehyde and 4% formaldehyde in 0.1 M
cacodylate buffer (pH 7.4); three washes in 0.1 M cacodylate buffer, postfixa-
tion with 1% osmium tetroxide and 1.5% potassium fericyanide, dehydration
with increasing concentrations of ethanol, and embedding in Agar 100 resin.
Ultra-thin sections cut by an LKB ultrotome 3 were stained with uranyl acetate
and lead citrate. Micrographs were taken with a Tecnai 12 electron micro-
scope (Phillips, Eindhoven, the Netherlands) equipped with a Megaview II
CCD camera and an Analysis version 3.0 software (Soft Imaging System
GmbH, Munster, Germany).
Phagocytosis Assays
Pigmented clusters were incubated with 1 mm green fluorescent latex beads
(Polysciences Inc, Warrington, PA) 1.0 3 109 beads/mL for 18 hr at 37C,
washed with PBS, dissociated, plated on poly-D-lysine for 2 hr, and stained
with red fluorescent dye, PKH (Sigma). Alternatively, the pigmented clusters
were incubated with purified mouse outer segments stained with N,N’-didan-
syl cystine (DDC; Sigma) for 4 hr, washed, incubated within KOM+NIC on poly-
D-lysine and laminin for 18 hr, and fixated; nuclei were counterstained with
DRAQ5 (Alexis Corporation, Lausen, Switzerland); and analysis was done
with a confocal microscope (Olympus Fluoview FV1000, Olympus Life And
Material Science Europa GmbH, Hamburg, Germany).
Flow Cytometry
Differentiating clusters were dissociated with 0.04% Trypsin/0.04% EDTA,
stained with anti-PSA-NCAM or anti-Tra-1-60 antibodies (Chemicon; 1:100),
detected with FITC (DakoCytomation; 1:100) or APC (SouthernBiotech,
Birmingham, AL, 1:500) conjugated goat anti-mouse Ig, and counterstained
with propidium iodide (PI; 0.005 mg/ml, Sigma). Control cells were incubated
with only the secondary antibody. Annexin V expression was analyzed with
MEBCYTO-Apoptosis kit (Medical & Biological Laboratories, Nagoya, Japan).
Cells were analyzed with FACScalibur (Becton Dickinson Immunocytometry
Systems) via CellQuest software.
Transplantation of hESC-Derived RPE Cells in RCS Rats
Pigmented areas, mechanically dissected from eGFP+ hESCs clusters (Gropp
et al., 2003) after 6–9weeks’ differentiation, were dissociated by Papain Disso-
ciation System and trituration and transplanted into 3-week-old outbred RCS
rats. All animal experiments were conducted according to the ARVO State-
ment for the Use of Animals in Ophthalmic and Vision Research and approved
by the Institutional Committee for Animal Research of the Hebrew University-
Hadassah Medical School. Animals were anesthetized with intraperitoneal
injection of ketamine HCl (Ketalar, Parke Davis, UK; 100 mg/kg) and xylazine
(2.0 mg/kg; Tiferet Hacarmel-Medical Market, Israel). Local anesthetic drops
(benoxinate HCl 0.4%; Fischer Pharmaceuticals, Israel) were administered.
The pupils were dilated with Tropicamide 0.5% (mydramide, Fisher Pharma-
ceuticals) and phenylephrine HCl 2.5% (Fisher Pharmaceuticals). Under visu-
alization with a dissecting microscope (Stemi SV 11, Zeiss, Germany), 0.6–13
105 pigmented cells, human Tenon’s capsule fibroblasts from a primary
culture, or mitomycin-treated human foreskin fibroblasts in 2–3 ml of KOM+NIC
were injected into the subretinal space or vitreus via a transscleral, transchor-
oidal approach through a glass capillary coupled to a pneumatic Pico-injector
(PLI-100; Medical System Corp., Greenvale, NY). Cyclosporine A (210 mg/l;
Sandimmune, Novartis Pharma AG, Basel, Switzerland) was administered in
the drinking water.
In Vivo and Ex Vivo Imaging of Transplanted Cells
Animals were anesthetized and their pupils were dilated as above. A color
fundus camera (Zeiss, Germany) and fluorescein filters on a scanning laser
ophthalmoscope (SLO; Heidelberg HRA, Germany) were used. Prolonged
acquisition times on a fluorescent microscope (Olympus BX41 Japan) were
used for imaging eye-cup preparations.
Assessment of Host Retinal Function after Intraocular
Transplantation
Full-field ERGs were recorded after overnight dark adaptation. Animals were
anesthetized in dim red light, and the pupils were dilated as above. Monopolar
rat ERG lens electrodes (Medical Workshop, Amsterdam, Netherlands) were406 Cell Stem Cell 5, 396–408, October 2, 2009 ª2009 Elsevier Inc.placed on each eye after additional topical anesthesia, with a reference elec-
trode and a ground electrode placed on the tongue and tail, respectively. A
commercial computerized ERG system (UTAS 3000, LKC technologies or
Espion E2, Diagnosys Llc) was used to record retinal responses to full-field
stimuli generated with a xenon photostrobe flash (Grass, PS-22) mounted on
a Ganzfeld bowl. Dim white flashes under scotopic conditions were used to
elicit a largely rod-driven response. At stronger stimulus intensities in the
dark-adapted state, mixed cone-rod responses were recorded. Under light-
adapted (photopic) conditions, with white flashes on a rod-suppressing
34 cd/m2 white background, 1 Hz and 16 Hz cone responses were generated.
Signals were filtered between 0.3 and 500 Hz, and signal averaging was used.
Histological and Immunohistochemical Evaluation
of Transplanted Eyes
After fixation in Davidson solution, eyes were embedded in paraffin and
sectioned at 4 mmserial sections. Each fifth slide was stained with hematoxylin
and eosin (H&E). For immunostaining, specimens were deparaffinized in
xylene, dehydrated in graded alcohols, rinsed with PBS (pH 7.4), incubated
with 10 mM citrate buffer (pH 6.0) at 110C for 4 min, washed with PBS,
blocked 1 hr with 1% bovine serum albumin, 0.1% Triton X-100 (Sigma),
and 3% normal goat or normal donkey serum (Jackson ImmunoResearch
Laboratories) in PBS, and incubated for 1–12 hr in a humidified chamber
with primary and secondary antibodies (Supplemental Data). Nuclei were
counterstained with DAPI or PI 1 mg/ml (BioLegend, San Diego, CA). Controls
were incubated with an irrelevant isotype-matched antibody. An Olympus
BX41 microscope with a DP70 digital camera (Olympus, Japan) and an
Olympus Fluoview 300 (FV300) confocal microscope (Olympus, Japan) built
around an IX70 inverted microscope. 488 nm Ar, 543 HeNe Green, and 633
HeNe Red lasers were used for imaging.
Quantification of Photoreceptor Layer Rescue in Vicinity
to RPE Grafts
Montages of the full length of the retina were constructed from high-resolution
microscopic images of H&E-stained sections with Photoshop software
(Adobe, USA). Total retinal, ONL, and IS+OS thicknesses were measured in
proximity to subretinal grafts and corresponding opposite side of the retina,
in areas that were of equal distance from the cilliary body, via the J-image
program (NIH). In each area, R3 equally spaced measurements were
averaged.
Statistical Analysis
Data are presented asmean ± SEM. Significance was calculated with one-way
ANOVA followed by the post hoc test for multiple comparisons (with a = 0.05),
or two-tailed t test, as appropriate.
ACCESSION NUMBERS
Microarray data are available at the NCBI Gene Expression Omnibus database
with accession number GSE16919.
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Supplemental Data include Supplemental Experimental Procedures, seven
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